The IP Podcast (Ep: 14) - Norwegian Life Sciences, the Oslo Cancer Cluster and life as a biotech start-up
In this very special podcast, we take a look at the Life Sciences sector in Norway and how this is one of the country's fastest growing...
Contributors
-
Trade Mark Attorney -
Trade Mark Attorney -
Partner -
Partner -
Senior Associate -
Patent Attorney -
-
Senior Associate -
Senior Associate -
Senior Associate -
-
Trade Mark Attorney -
Associate Patent Attorney -
Trade Mark Attorney -
Partner -
Partner -
Technical Assistant -
Marketing and Communications Manager -
Head of Business Development -
Trade Mark Assistant -
Partner -
Associate -
IP Consultant -
Partner
Dehns Insights Archive
- December 2020 (1)
- November 2020 (1)
- October 2020 (3)
- September 2020 (5)
- August 2020 (6)
- July 2020 (13)
- June 2020 (9)
- May 2020 (1)
- April 2020 (2)
- March 2020 (3)
- February 2020 (3)
- January 2020 (4)
- November 2019 (4)
- October 2019 (1)
- August 2019 (1)
- July 2019 (2)
- June 2019 (2)
- April 2019 (4)
- March 2019 (2)
- February 2019 (3)
- January 2019 (6)
- December 2018 (2)
- November 2018 (8)
- October 2018 (3)
- September 2018 (7)
- August 2018 (3)
- July 2018 (3)
- June 2018 (6)
- May 2018 (7)
- April 2018 (14)
- March 2018 (12)
- February 2018 (8)
- January 2018 (8)
- December 2017 (8)
- November 2017 (3)
- October 2017 (12)
- September 2017 (8)
- August 2017 (6)
- July 2017 (5)
- June 2017 (7)
- May 2017 (5)
- April 2017 (3)
- March 2017 (5)
- February 2017 (5)
- January 2017 (3)
- December 2016 (1)
- November 2016 (7)
- October 2016 (7)
- September 2016 (12)
- August 2016 (9)
- July 2016 (6)
- June 2016 (13)
- May 2016 (34)
Webinar: Patenting Medical and Biotech Inventions
Hosted by Philip Webber on 9 July 2020, this webinar covers what can be patented in the medical and biotech fields, and looks at...
BAT - another remarkable transformation
We recently published an article looking at how multinationals are diversifying into new markets and sectors through the process (and...
AI drug discovery comes of age
Bringing a new drug to the clinic is a tortuous and extremely expensive process fraught with commercial risk. It seems that Artificial...
CRISPR Patent Portfolio edited: The Broad Institute has lost its appeal on a key CRISPR patent in Europe
As I have discussed previously here, CRISPR-based techniques have revolutionized the field of gene editing in recent years. The Broad...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
-
Search site
-
Contact our offices